Growth Metrics

Innoviva (INVA) EBT (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,796.90%
Dec 31, 2025 -114.13%
Sep 30, 2025 34.74%
Jun 30, 2025 288.13%
Mar 31, 2025 -266.15%
Dec 31, 2024 -253.88%
Sep 30, 2024 117.44%
Jun 30, 2024 -187.05%
Mar 31, 2024 785.98%
Dec 31, 2023 -107.65%
Sep 30, 2023 1,380.65%
Jun 30, 2023 -85.89%
Mar 31, 2023 498.33%
Dec 31, 2022 -103.61%
Sep 30, 2022 1,297.53%
Jun 30, 2022 -54.17%
Mar 31, 2022 839.38%
Dec 31, 2021 -104.91%
Sep 30, 2021 -9.55%
Jun 30, 2021 5.21%
Mar 31, 2021 42.61%
Dec 31, 2020 79.77%
Sep 30, 2020 -57.26%
Jun 30, 2020 24.48%
Mar 31, 2020 35.04%
Dec 31, 2019 21.97%
Sep 30, 2019 1.97%
Jun 30, 2019 16.42%
Mar 31, 2019 -33.65%
Dec 31, 2018 45.80%
Sep 30, 2018 -11.39%
Jun 30, 2018 86.67%
Mar 31, 2018 0.07%
Dec 31, 2017 -10.93%
Sep 30, 2017 -5.30%
Jun 30, 2017 113.91%
Mar 31, 2017 -32.35%
Dec 31, 2016 65.80%
Sep 30, 2016 16.30%
Jun 30, 2016 188.29%
Mar 31, 2016 3.86%
Dec 31, 2015 193.83%
Sep 30, 2015 41.31%
Jun 30, 2015 26.78%
Mar 31, 2015 33.02%
Dec 31, 2014 26.09%
Sep 30, 2014 -8.43%
Jun 30, 2014 -22.81%
Mar 31, 2014 -81.94%
Dec 31, 2013 5.92%
Sep 30, 2013 -513.50%
Jun 30, 2013 95.71%
Mar 31, 2013 17.33%
Dec 31, 2012 -25.31%
Sep 30, 2012 6.54%
Jun 30, 2012 -143.88%
Mar 31, 2012 328.59%
Dec 31, 2011 -20.84%
Sep 30, 2011 -22.28%
Jun 30, 2011 -9.79%
Mar 31, 2011 -17.35%
Dec 31, 2010 8.40%
Sep 30, 2010 -2.00%